Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Hypoglycemia - Overview
Hypoglycemia - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Hypoglycemia - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Hypoglycemia - Companies Involved in Therapeutics Development
Adocia SAS
AMAG Pharmaceuticals Inc
Arecor Ltd
Eiger BioPharmaceuticals Inc
Eli Lilly and Co
LATITUDE Pharmaceuticals Inc
Recordati SpA
Rezolute Inc
Sosei Heptares
Therakind Ltd
USV Pvt Ltd
XERIS Pharmaceuticals Inc
Zealand Pharma AS
Zucara Therapeutics Inc
Hypoglycemia - Drug Profiles
avexitide acetate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Baqsimi - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
dasiglucagon - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Drug for Hypoglycemia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
glucagon - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
glucagon - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
glucagon - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
glucagon - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
glucagon - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
glucagon biosimilar - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
pasireotide - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
RZ-358 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Antagonize GLP-1 Receptor for Congenital Hyperinsulinism and Hypoglycemia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ZT-01 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Hypoglycemia - Dormant Projects
Hypoglycemia - Discontinued Products
Hypoglycemia - Product Development Milestones
Featured News & Press Releases
Appendix



List of Figures


Number of Products under Development for Hypoglycemia, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products by Targets, H2 2019
Number of Products by Stage and Targets, H2 2019
Number of Products by Mechanism of Actions, H2 2019
Number of Products by Stage and Mechanism of Actions, H2 2019
Number of Products by Routes of Administration, H2 2019
Number of Products by Stage and Routes of Administration, H2 2019
Number of Products by Molecule Types, H2 2019
Number of Products by Stage and Molecule Types, H2 2019


List of Tables


Number of Products under Development for Hypoglycemia, H2 2019
Number of Products under Development by Companies, H2 2019
Products under Development by Companies, H2 2019
Number of Products by Stage and Target, H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Hypoglycemia - Pipeline by Adocia SAS, H2 2019
Hypoglycemia - Pipeline by AMAG Pharmaceuticals Inc, H2 2019
Hypoglycemia - Pipeline by Arecor Ltd, H2 2019
Hypoglycemia - Pipeline by Eiger BioPharmaceuticals Inc, H2 2019
Hypoglycemia - Pipeline by Eli Lilly and Co, H2 2019
Hypoglycemia - Pipeline by LATITUDE Pharmaceuticals Inc, H2 2019
Hypoglycemia - Pipeline by Recordati SpA, H2 2019
Hypoglycemia - Pipeline by Rezolute Inc, H2 2019
Hypoglycemia - Pipeline by Sosei Heptares, H2 2019
Hypoglycemia - Pipeline by Therakind Ltd, H2 2019
Hypoglycemia - Pipeline by USV Pvt Ltd, H2 2019
Hypoglycemia - Pipeline by XERIS Pharmaceuticals Inc, H2 2019
Hypoglycemia - Pipeline by Zealand Pharma AS, H2 2019
Hypoglycemia - Pipeline by Zucara Therapeutics Inc, H2 2019
Hypoglycemia - Dormant Projects, H2 2019
Hypoglycemia - Discontinued Products, H2 2019